Replies to post #317195 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

As I pointed out in a previous post. Biomarkers are one of two criteria that can be used for AA. The other is Clinical Benefit.

...or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality (IMM) that is reasonably likely to predict an effect on IMM or other clinical benefit (i.e., an intermediate clinical endpoint)

[TWilson07]

This is nonsense. There's no conspiracy, or confirmation of super-duper fantasies.